Naphazoline/pheniramine
| Combination of | |
|---|---|
| Naphazoline | Vasoconstrictor |
| Pheniramine | Antihistamine |
| Clinical data | |
| Trade names | Naphcon-A, Opcon-A, Visine-A, others |
| AHFS/Drugs.com | Multum Consumer Information |
| Routes of administration | Eye drop |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
Naphazoline/pheniramine, sold under the brand name Naphcon-A among others, is a combination eye drop used to help the symptoms of allergic conjunctivitis such as from hay fever.[2] It contains naphazoline and pheniramine.[2][1] It is used as an eye drop.[1] Use is not recommended for more than three days.[3]
Side effects may include allergic reactions, eye pain, and dilated pupils.[2][4][3] It is unclear if use in pregnancy is safe.[1] Nephazoline works by resulting in constriction of blood vessels thus decreasing redness while pheniramine works by blocking the effects of histamine to stop itching.[1]
The combination was approved for medical use in the United States in 1994.[5][6][1] It is available over the counter.[5][6][2] In 2017, it was the 203rd most commonly prescribed medication in the United States, with more than two million prescriptions.[7][6]
Medical use[edit]
It is administered topically with one to two drops applied to the affected eye(s) up to four times daily.[2]
Adverse effects[edit]
 |
- Pupils may become enlarged temporarily
- Overuse may cause more redness
- Those with heart disease, high blood pressure, narrow angle glaucoma or who have urination trouble are discouraged from using the product
- It is recommended to remove contact lenses before use. Use with contact lenses can lead to reduced oxygenation of the underlying cornea
- If infants or children accidentally ingest the drops, it may lead to coma and significant reduction in body temperature. If such ingestion occurs, immediately calling a poison control center is recommended[2]
References[edit]
- ^ a b c d e f "Naphazoline and pheniramine ophthalmic Uses, Side Effects & Warnings". Drugs.com. Retrieved 19 April 2019.
- ^ a b c d e f "Naphcon A- naphazoline hydrochloride and pheniramine maleate solution/ drops". DailyMed. 16 September 2019. Retrieved 10 August 2020.
- ^ a b Kizior RJ, Hodgson BB (2014). Saunders Nursing Drug Handbook 2015 - E-Book. Elsevier Health Sciences. p. 163. ISBN 9780323280181.
- ^ "Naphazoline/pheniramine ophthalmic Side Effects in Detail". Drugs.com. Retrieved 19 April 2019.
- ^ a b "Naphcon-A: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Retrieved 19 April 2020.
- ^ a b c "Naphazoline Hydrochloride; Pheniramine Maleate - Drug Usage Statistics". ClinCalc. Retrieved 11 April 2020.
- ^ "The Top 300 of 2020". ClinCalc. Retrieved 11 April 2020.
External links[edit]
- "Naphazoline hydrochloride mixture with pheniramine maleate". Drug Information Portal. U.S. National Library of Medicine.
